p38 MAP Kinase Inhibitor III

• CAT Number: R066621
• CAS Number: 581098-48-8
• Molecular Formula: C23H21FN4S
• Molecular Weight: 404.50
• Purity: ≥95%
• Synonyms: 4-[5-(4-fluorophenyl)-2-methylsulfanyl-1H-imidazol-4-yl]-N-[(1S)-1-phenylethyl]pyridin-2-amine
• IUPAC Name: 4-[5-(4-fluorophenyl)-2-methylsulfanyl-1H-imidazol-4-yl]-N-(1-phenylethyl)pyridin-2-amine
• InChI: InChI=1S/C23H21FN4S/c1-15(16-6-4-3-5-7-16)26-20-14-18(12-13-25-20)22-21(27-23(28-22)29-2)17-8-10-19(24)11-9-17/h3-15H,1-2H3,(H,25,26)(H,27,28)
• InChIKey: VXPWQNBKEIVYIS-UHFFFAOYSA-N
• SMILES: CC(C1=CC=CC=C1)NC2=NC=CC(=C2)C3=C(NC(=N3)SC)C4=CC=C(C=C4)F

p38 MAP Kinase Inhibitor III（Cat No.:R066621）is a potent, selective inhibitor of p38 mitogen-activated protein kinase (MAPK), a key enzyme involved in inflammatory and stress-related pathways. It is primarily used in research to explore the role of p38 MAPK in various diseases, including cancer, cardiovascular disorders, and inflammatory conditions. By inhibiting p38 MAPK, it modulates inflammatory responses, apoptosis, and cell proliferation. This inhibitor is valuable in studying inflammatory diseases, neurodegenerative disorders, and other conditions linked to abnormal p38 MAPK activity, offering insights for potential therapeutic development.